Literature DB >> 15277296

Perioperative systemic haemostatic agents.

A M Mahdy1, N R Webster.   

Abstract

Skilful surgery combined with blood-saving methods and careful management of blood coagulation will all help reduce unnecessary blood loss and transfusion requirements. Excessive surgical bleeding causes hypovolaemia, haemodynamic instability, anaemia and reduced oxygen delivery to tissues, with a subsequent increase in postoperative morbidity and mortality. The role of anaesthetists in managing surgical blood loss has increased greatly in the last decade. Position of the patient during surgery and the provision of a hypotensive anaesthetic regimen were once considered the most important contributions of the anaesthetist to decreasing blood loss. Now, several pharmacological haemostatic agents are being used by anaesthetists as blood-saving agents. After a brief discussion of the physiology of haemostasis, this article will review the evidence for the role of such agents in reducing perioperative blood loss and transfusion requirements.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277296     DOI: 10.1093/bja/aeh227

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  24 in total

1.  Comparison of aprotinin and tranexamic acid in adult scoliosis correction surgery.

Authors:  Ashish Khurana; Abhijit Guha; Niraj Saxena; Steve Pugh; Sashin Ahuja
Journal:  Eur Spine J       Date:  2012-03-09       Impact factor: 3.134

Review 2.  [Local and systemic hemostasis in surgery].

Authors:  W O Bechstein; C Strey
Journal:  Chirurg       Date:  2007-02       Impact factor: 0.955

Review 3.  Is there still a role for aprotinin in cardiac surgery?

Authors:  Neel R Sodha; Munir Boodhwani; Frank W Sellke
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage.

Authors:  Kevin Fleming; Roberta E Redfern; Rebekah L March; Nathan Bobulski; Michael Kuehne; John T Chen; Michael Moront
Journal:  J Extra Corpor Technol       Date:  2017-12

Review 5.  [Coagulopathy in multiple trauma: new aspects of therapy].

Authors:  O Grottke; D Henzler; D R Spahn; R Rossaint
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

6.  Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials.

Authors:  Priscilla S Briquez; Kristen M Lorentz; Hans M Larsson; Peter Frey; Jeffrey A Hubbell
Journal:  Biomaterials       Date:  2017-04-29       Impact factor: 12.479

7.  Tranexamic acid administration to older patients undergoing primary total hip arthroplasty conserves hemoglobin and reduces blood loss.

Authors:  Hossam El Beheiry; Ashley Lubberdink; Nigel Clements; Kiran Dihllon; Vicky Sharma
Journal:  Can J Surg       Date:  2018-06       Impact factor: 2.089

8.  Perioperative tranexamic acid in day-case paediatric tonsillectomy.

Authors:  P J Robb; G Thorning
Journal:  Ann R Coll Surg Engl       Date:  2014-03       Impact factor: 1.891

Review 9.  [Procedure for critical nonsurgical bleeding].

Authors:  O Grottke; R Rossaint
Journal:  Chirurg       Date:  2007-02       Impact factor: 0.955

10.  Carbon Nanotube Strain Sensor Based Hemoretractometer for Blood Coagulation Testing.

Authors:  Zida Li; Yize Wang; Xufeng Xue; Brendan McCracken; Kevin Ward; Jianping Fu
Journal:  ACS Sens       Date:  2018-02-27       Impact factor: 7.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.